Home News Biomedical Structures, Modified Polymer Components Merge

Biomedical Structures, Modified Polymer Components Merge

Mergers/Acquisitions, Movers & Shakers

Companies plan to provide medical device OEMs with value-added design and contract manufacturing solutions.

Font size
Manufacturing Group February 5, 2013

Officials for Biomedical Structures (BMS) and Modified Polymer Components (MPC) have announced the companies' merger. Jointly, the companies will better provide medical device customers with a full spectrum of value-added services across a wider range of applications.  Ampersand Capital Partners will be the majority shareholder of the combined company.

BMS and MPC plan to provide medical device OEMs with value-added design and contract manufacturing solutions supported by the polymer expertise of both teams of engineers. From plastics to innovative biomaterials, the joint BMS-MPC team delivers sophisticated technical expertise in purpose-built material solutions for medical device engineers, and now ensures a commitment to customer service from coast to coast. BMS and MPC will presently retain existing names and headquarters, while pursuing opportunities to collaborate on value offerings to the medical device market. Dean Tulumaris will lead the combined company and Mike Taylor will transition into his new role of chief technical officer, where he will focus on working with the company’s engineers to develop new technologies and provide innovative solutions to their customers.

“We look forward to embracing our relationship with BMS and using our collective expertise to better serve medical device OEMs,” says Mike Taylor, CEO of MPC. “With our joint capabilities, we will be a more robust organization that will bring greater value to customers with a wider variety of needs, both related to custom plastics components and medical textiles.”

“MPC’s unique bonding technologies are enabling exciting developments with custom plastic components for medical devices and other related industries, and we are pleased to be joining the companies to expand both our offerings and theirs,” says Dean Tulumaris, CEO of BMS. “By merging BMS and MPC, both companies will benefit from a bicoastal presence and extensive combined resources, without affecting our existing commitments or the established level of superior quality and seamless operational efficiency our valued customers and employees have come to expect.”

The companies will be exhibiting at the MD&M West event from February 12-14 in Anaheim, CA.

Add a comment:

 

Post Comment
* TMD - Today's Medical Developments reserves the right to edit or remove reader comments for any reason it deems appropriate.